Skip to main content
. 2018 Feb 1;41(4):823–830. doi: 10.2337/dc17-1387

Table 1.

Subject characteristics, transplant history, diabetes medications, and causes of death

Non-CF (younger) Non-CF (older) CF-no DM CFRD
N 20 20 17 18
Age (years) 13.1 ± 6.8 28.0 ± 5.5*# 13.9 ± 8.3 28.6 ± 9.0*#
Sex (female/male) 12/8 9/11 12/5 10/8
BMI (kg/m2) 19.8 ± 7.0 22.6 ± 5.5# 16.5 ± 3.9 21.7 ± 3.3#
Diabetes duration (years) (n = 17) 4.80 ± 5.16
HbA1c (%) (n = 11) 7.25 ± 1.67
Lung transplant (yes/no/unknown) 0/19/0 0/20/0 4/13/0 10/6/2
Other transplant 1 (heart) 0 0 0
Diabetes medications
 Oral agent 1
 Insulin 16
 Unknown 2
Steroid use (yes/no/unknown) 4/13/3 0/15/5 4/13/0 11/5/2
Pancreatic enzyme supplementation (yes/no/unknown) 16/0/1 16/0/2
Cause of death
 Respiratory 5 5 14 14
 Cardiovascular 4 4 2
 CNS 3 6
 Infection 4 3
 Malignancy 2
 Multiorgan failure 1 2 3
 Unknown 1 1

Data are means ± SD or n. CNS, central nervous system.

*P < 0.05 vs. non-CF (younger).

#P < 0.05 vs. CF-no DM.